Newlink Genetics (NLNK) Posts Q3 Loss of 28c

Newlink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $327 thousand versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Newlink Genetics (NLNK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
• Agora Inc. (API) PT Raised to $6.80 at BofA Securities